Series A
$100M
Nextech Invest · LeadRA Capital Management · Leada16z Bio + Health · Lead
Open roles0
Total raised$100M
Team size1-10
Founded · Stage2022 · Series A
We pull jobs from sources most job seekers never check
About the company
What they build and who they serve.
Illuminating the Hidden Targets of Cancer | Stipple Bio is a biotechnology company harnessing epitope-level precision to create targeted cancer therapies through our proprietary Pointillist Platform, which is designed to identify tumor-specific cell surface epitopes with greater precision. By enabling more selective targeting of cancer cells, the platform aims to improve therapeutic index and unlock targets that have been difficult to address using conventional oncology drug discovery methods. We’re advancing our lead candidate ADC STP-100 as an early application of our epitope-targeting approach.
Funding history
Rounds and investors over time, newest first.
In the news
Press, announcements, and coverage about this company.
Investors
Nextech InvestRA Capital Managementa16z Bio + Health
Focus areas
Early StageBiotechnologyGenomicsMedtech
No open roles on the board yet
We do not have indexed listings for Stipple Bio right now. Roles may still be open on the company site—we will add them here when they appear in our feed.
Don’t get beat to tomorrow’s openings
New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job posts